FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes

Patent skyline
The USPTO and FDA were advised on patent policy changes to prevent unjustified delays in competition. • Source: Shutterstock

More from Legal & IP

More from Pink Sheet